Product
Quadrivalent Influenza mRNA Vaccine MRT5407
1 clinical trial
1 indication
Indication
Influenza ImmunizationClinical trial
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2024-01-19